Efficacy of heterologous boosting against SARS-CoV-2 using a recombinant interferon-armed fusion protein vaccine (V-01): a randomized, double-blind and placebo-controlled phase III trial
Xuan Yi Wang, Syed Faisal Mahmood, Fang Jin, Wee Kooi Cheah, Muhammad Ahmad, Mian Amjad Sohail, Waheed Ahmad, Vijaya K. Suppan, Muneeba Ahsan Sayeed, Shobha Luxmi, Aik Howe Teo, Li Yuan Lee, Yang Yang Qi, Rong Juan Pei, Wei Deng, Zhong Hui Xu, Jia Ming Yang, Yan Zhang, Wu Xiang Guan, Xiong Yu
Research output: Contribution to journal › Article › peer-review
30Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Efficacy of heterologous boosting against SARS-CoV-2 using a recombinant interferon-armed fusion protein vaccine (V-01): a randomized, double-blind and placebo-controlled phase III trial'. Together they form a unique fingerprint.